264 0 Li Wanxi 2016-8-22 publish Last reply on 2016-8-22 10:27
211 0 Li Wanxi 2016-8-22 publish Last reply on 2016-8-22 09:58
228 0 Li Wanxi 2016-8-22 publish Last reply on 2016-8-22 09:28
242 0 Fei Yifei 2016-8-22 publish Last reply on 2016-8-22 09:23
317 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 12:03
255 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 11:41
280 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 11:14
270 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 10:42
338 0 Fei Yifei 2016-8-20 publish Last reply on 2016-8-20 21:47
251 0 Xinjiang Wanyintong 2016-8-20 publish Last reply on 2016-8-20 20:23
310 0 Xinjiang Wanyintong 2016-8-20 publish Last reply on 2016-8-20 19:57
319 0 Wuhan Medical 2016-8-20 publish Last reply on 2016-8-20 15:40
223 0 special characteristics 2016-8-20 publish Last reply on 2016-8-20 09:32
216 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 16:36
243 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 14:56
256 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 11:52
244 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 10:29
259 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 09:23
304 0 special characteristics 2016-8-19 publish Last reply on 2016-8-19 09:03
259 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 19:22
213 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 17:20
255 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 16:14
295 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 13:00
252 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 11:19
263 0 Li Wanxi 2016-8-18 publish Last reply on 2016-8-18 11:17
Point rules of this version Post Rebroadcast to the audience